INTRODUCTION
The presence of colonies of stem cells in many organs and tissues of adult humans has favoured the development of tissue engineering. The latter has been more or less widely used in orthopaedics, ophthalmology as well as in the treatment of ulcers and burns [1] . Tissue engineering has allowed the development of skin substitutes (bioengineered skin) with the purpose of fast cell growth and reproduction without any risk of infection [2] . Our studies are focussed on the isolation of human basal keratinocytes and fibroblasts from autologous biopsied skin samples and on their proliferation in culture flasks. Autologous plasma is subsequently used as scaffold for the formation of skin grafts whose morphofunctional and immunohistochemical characteristics are similar to those of normal skin.
Plasma has all the essential characteristics to be an excellent support biomaterial, that is to say, a material is devised to interface with biological systems for the purpose of treating, increasing or replacing any type of tissue or organ. Plasma, in fact, is well tolerated by patients and is replaced by tissue after integration. Moreover, the cells within the plasma can communicate and exchange signals both with one another and with the host cells. In the past, keratinocyte cultures were used for the treatment of ulcers and burns thanks to their high capacity for in vitro expansion. However, in many cases, dermal loss poses a serious problem for the grafting of keratinocytes themselves and for this reason artificial matrixes or cadaver skin is used. Consequently, we have devised a method for dermal regeneration using autologous fibroblasts immersed in a matrix of human plasma so as to eliminate any problem linked to the safety of the sample and rejection from a patient [3] [4] . On this new dermis, keratinocytes have Basic Experiment www. CRTER.org then been seeded and the interaction of fibroblasts and keratinocytes has led to the formation of the basement membrane. Culturing keratinocytes and fibroblasts can then constitute a viable alternative to conventional therapies for reconstructive surgery in case of burns, diabetic or vascular ulcers (both arterial and venous) or ulcers due to high blood pressure. These pathologies affect elderly people chronically, and thus increase their socio-economic impact [5] .
SUBJECTS/MATERIALS AND METHODS

Subjects and materials
Normal cells can be kept in vitro in flasks or in Petri dishes for a duration that depends on the cell type and the conditions of the culture. Important factors for cell cultures are the density of the seeding, the choice of medium, scaffold cells and incubation conditions. The seeding density affects cellular growth to a considerable extent as cells grow better above a certain density. This is due to interaction among cultured cells and it is likely to be connected to the production of factors such as cytokines which affect cellular proliferation. Common mediums such as MEM (Minimal Essential Medium) and DMEM (Dulbecco Modified Eagle's Medium) contain, besides buffers and PH indicators, inorganic salts, vitamins, nitrogenous bases, carbohydrates, lipids and aminoacids, both essential and non-essential. These mediums need to be supplemented with varying quantities of animal serum (for example fetal bovine serum). The medium must be changed every 2 to 5 days depending on the metabolic consumption and cellular density. The culture is often supplemented with another cellular type acting as support to the cells to be cultured so as to allow a considerably lower seeding density. In the case of keratinocytes, this function is performed by 3T3 fibroblasts (a stabilized line derived from Swiss strain embryonic mouse fibroblasts). The cultures are stored in 5% CO 2 incubators at 37 ℃ . Culture sterility is ensured by the medium, sterile materials and handling in a controlled environment (vertical laminar flow cabinet) [6] .
The human keratinocytes and fibroblasts used for this research were taken from a skin fragment after mastectomy in a 58-year-old patient. The experiment was approved by the independent ethics committee of C. Poma Hospital and the patient was requested to give informed consent. ℃ . This neutral protase acts as a type 4 collagenase and separates the dermis from the epidermis in the region of the lamina lucida. At this point, the dermis and the epidermis part ways.
Extraction of human keratinocytes and fibroblasts
Human fibroblasts
Fibroblasts extraction from the dermis Once separated from the epidermis, the dermis must be further fragmented, immersed in collagenase (crude type I, Sigma-Aldrich) and stored in a 5% CO 2 incubator for 7 hours. A specific medium, supplemented with serum 25%, is prepared in order to stop the action of collagenase. Later, the solution is filtered through a 70 μm sterile filter and the cells are centrifuged at 1 200 rpm for 10 minutes.
Seeding procedure of extracted fibroblasts
The cells are re-suspended in a suitable quantity of medium, counted in the Burker chamber, and then seeded in a flask with DMEM medium supplemented with fetal bovine serum 10%, 4 mmol/L glutamine, 50 IU/mL penicillin-streptomycin and 50 mL/100 mL fungizone. The culture is stored in a 5% CO 2 incubator and the medium is changed every 72 hours.
Trypsinization of human fibroblasts
Once the fibroblasts have come to a confluence, the medium that contained them is removed and the flask is washed with PBS. Then 10 mL trypsin 0.05%/EDTA 0.02% is added and the solution is placed in a thermostated bath for 5 minutes. When the fibroblasts have become detached from the flask, an equal quantity of fibroblast medium is added to block the action of trypsin. After centrifugation at 1 200 r/min for 10 minutes, the pellet obtained is suspended in a suitable quantity of fibroblast medium. Finally, the cells are counted using a microscope with the Burker chamber and seeded in new flasks.
Human keratinocytes Extraction of keratinocytes from the epidermis
The epidermis is treated with trypsin 0.05%/EDTA 0.02% in a thermostated bath for 30 minutes. Also in this case, a pipette should be used for 5 minutes to separate the keratinocytes. The action of trypsin is blocked with medium supplemented with serum 25%. Later, the solution is filtered with a 100 μm filter and the cells are centrifuged at 1 200 r/min for 10 minutes.
Seeding procedure of extracted keratinocytes
The pellet obtained is re-suspended in a suitable quantity of keratinocyte medium. The cells are counted with the Burker chamber and then seeded in a flask with a suitable amount of Swiss strain 3T3 mouse fibroblasts irradiated with 7000 RAD (seeded the day before or on the same day as the keratinocytes). The medium employed consists of a mixture of DMEM/HAM F-12 supplemented with 4mM glutamine, 50 IU/mL penicillin-streptomycin, insulin 6 mg/mL, transferrin 5 mg/mL, adenin 0.18 mM, hydrocortisone 0.4 mg/mL, triiodo-thyronine 20 pmol/L, choleric toxin 0,1 nmol/L, epidermal growth factor (EGF) 10 ng/mL, 10% fetal bovine serum, 50 mL/100 mL fungizone. It should be remembered that the EGF must be added only 48 hours after the beginning of the culturing process in order to synchronize cellular growth [7] . The culture is stored in a 5% CO 2 incubator and the medium is changed every 48 hours.
Trypsinization of human keratinocytes
Once the keratinocytes have reached sub-confluence, the www.CRTER.org medium is removed and the flask is washed with PBS. 3T3 fibroblasts are eliminated by incubation for 5 minutes with 10 mL PBS/EDTA 0.02%. After removal, and another washing with PBS, 10 mL trypsin 0.05%/EDTA 0.02% are added. After ten/fifteen minutes storage in a CO 2 5% incubator, the action of trypsin is blocked by adding an equal quantity of medium containing serum 25%. After centrifugation, the pellet obtained is re-suspended in a suitable quantity of medium for cellular count. The cells obtained are re-seeded in new flasks with an adequate amount of 3T3 fibroblasts.
Cryopreservation of keratinocytes and fibroblasts
If the fibroblasts and keratinocytes are not used immediately, they can be cryopreserved. 2×10 6 cells are re-suspended in 900 mL of medium with 100 mL of DMSO. The cells are then stored in a freezer at a temperature of -80 ℃ for up to a week and subsequently immersed in liquid nitrogen.
Preparation of the human plasma scaffold
When a suitable amount of fibroblasts and keratinocytes has been obtained, the preparation of the autologous human plasma scaffold can be started. For this purpose, tranexamic acid is dissolved in the plasma and then physiological solution and calcium chloride are added. At the same time the plasma matrix is supplemented with fibroblasts. The suspension obtained is placed on multiwell plates which are stored in a 5% CO2 incubator at 37 ℃ for 30 minutes. This procedure enables the plasma scaffold to solidify thanks to the presence of tranexamic acid and calcium chloride (its substrate). The combination of these 2 substances enables the solution to acquire gel-like density. Keratinocytes are seeded on the matrix; the scaffold is covered with a layer of culture medium and then stored in an incubator for 10-12 days to allow cellular growth. The medium is changed every 48 hours. Different tests have been made to obtain the best possible scaffold. The scaffold has been placed on a multiwell plate (a plate with 12 wells, each with a surface of 3.14 cm 2 ) and the quantities of its components have been changed: CaCl 2 (1 mL 1% and 1 mL 1.5%); Tranexamic acid (5 mg and 6 mg); Plasma (5 mL and 6 mL); Physiological solution (6.5 mL and 5.5 mL). 64 cross tests have been carried out which maintain the final quantity of solution at 2 mL in each well. The purpose of these tests is to obtain a fairly solid plasma matrix. The objective density has been assessed by lifting the scaffold with sterile pliers and timing how long it took to break. The next step is to carry out 9 cross tests which vary the cellular density of the fibroblasts and keratinocytes (Table 1) .
Finally the seeding times of the keratinocytes have been modified: on the same day when the fibroblasts are added to the scaffold, and after 1, 4 or 8 days.
Histological and immunohistochemical examination
Every three days a 1-cm fragment of the support with fibroblasts and keratinocytes is taken in sterile conditions and immersed in fixative liquid (10% formalin) for a minimum of two hours. The sample is then subjected to dehydration, clarification and inclusion. Dehydration is done by passing the sample through a series of alcohol concentrations progressively increasing from 70% to 100%, for times varying from 40 minutes to 1 hour. The next phase is clarification in xylene. The pieces are then embedded in paraffin and allowed to solidify in special moulds. 3-µm microtome sections of the sample are spread out in a thermostated water bath (37 ℃ ) and then collected in histology slides. The slides are dried, the paraffin wis removed first by treatment with xylene and then with a decreasing series of alcohol concentrations (100%, 95%, 50%). Sections were then re-hydrated by passing through water. One section is stained with haematoxylin-eosin. This is a routine procedure based on the staining affinity of the cellular structures for various stains: aqueous solutions of haematoxylin (basic) stain the nuclei (containing nucleic acids) purplish-blue and alcoholic eosin solutions (acid) stain the cytoplasm (rich in basic proteins) red-orange. The section is immersed in haematoxylin for 16 minutes, washed in tap water, immersed in 95% alcohol, stained with alcoholic eosin, dehydrated in alcohol, clarified in xylene, and mounted with balsam. In order to evaluate the results of the above-mentioned tests the samples are viewed through a microscope counting the number of cells in 5 40-fold fields. Additional sections underwent immunohistochemical examination for vimentin, keratin-AE1, and AE3, collagen Ⅳ , P63 and Mib1 (all antibodies of Bio-optica). Bound primary antibodies are revealed with biotin-labeled secondary antibodies and avidin-conjugated peroxidase. Stained sections are counter-stained with haematoxylin.
RESULTS
The keratinocytes are obtained from the primary culture (Figure 1 ) which is then re-seeded to form a secondary culture on feeder-layer.
Simultaneously, the fibroblasts are expanded in a separate flask (Figure 2 ). Once the optimal quantity of fibroblasts has been obtained, they are seeded inside the plasma scaffold (Figure 3) . When the plasma scaffold is ready, the keratinocytes can be seeded (Figure 4 ). As far as the composition of the scaffold is concerned, the following quantities yielded the best result as the fragment broke in 1 minute and 30 seconds: 5 mL plasma, 5 mg tranexamic acid, 6.5 mL physiological solution and 1 mL CaCl 2 1%.
As to the seeding density, both fibroblasts and keratinocytes can expand and differentiate optimally at a density of 15×10 4 /cm 2 .
As for the seeding time of keratinocytes, the best results were obtained when they were seeded simultaneously with fibroblasts or the day after. Finally, results showed that cells reached their optimal growth after 13 days; the fibroblast and keratinocyte reached a density of 9.2×10 5 and 10.4×10 5 respectively.
After 13 days the fragment underwent histochemical ( Figures  5-7) and immunohistochemical examination.
The presence of fibroblasts and keratinocytes is highlighted on immunohistochemical test for vimentin and keratin AE1 (Figures 8,  9 ). 
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Immunohistochemical examination for collagen IV revealed the presence of basement membrane ( Figure 10 ) while immunohistochemical examination for Mib 1 (Figure 11 ) assessed the cell proliferation index. Basal stem cells were highlighted on immunohistochemical examination for P63 (Figure 12 ).
DISCUSSION
Tissue bioengineering is an important innovative field of research whose purpose is the regeneration of damaged organs and tissues. Bioengineered skin can be employed in the treatment of surgery-related skin loss such as injuries due to the removal of skin lesions (giant nevi) [8] , reconstruction of critical facial areas (maxillo-facial or ear surgery) or coverage after laser-resurfacting or dermabrasion. Moreover, bioengineered skin can reveal itself extremely useful in case of post traumatic skin loss caused by extensive, partial or full-thickness burns, limited or full-thickness burns in critical sites (face, palmar or plantar areas) or full-thickness injuries (scalping, lacerations and contusions). Furthermore, skin substitutes can be custom designed to treat skin loss due to pathologies such as Lyell syndrome, congenital epidermolysis bullosa and chronic ulcers [1, 5, 9] .
Recently bioengineered epidermis has been successfully employed in the treatment of vitiligo [10] as the patient's keratinocytes and melanocytes can be cultured and expanded and then grafted in order to obtain the re-pigmentation of achromatic areas. Finally, bioengineering skin can offer new opportunities for the treatment of photoaging thanks to the steady improvements in research on chronic alterations due to sun-related damage and on tissue repair techniques [11] . This therapeutical approach
gives excellent results as it eliminates cells which suffered prolonged damage (exposure to light and ageing) and replaces them with undamaged cells. The skin grafts obtained in our study consist of few layers of normally-shaped keratinocytes on a plasma matrix with fibroblasts embedded inside. Keratinocytes and fibroblasts are interacted with each other to maintain skin integrity. Fibroblast influence keratinocyte proliferation, differentiation and migration processes involved in epidermal homeostasis and reepithelialization after epidermal damage. Fibroblast-keratinocyte interactions are involved in the formation of the basement membrane zone, which is essential for attachment of the epidermis to the dermis. The formation of basement membrane shows that autologous plasma is a good scaffold for the growth, differentiation and expansion of keratinocytes and fibroblasts and that dermal and epidermal cells can interlock to reconstruct artificial grafts identical to normal skin [12] .
In particular, we have observed that fibroblast-enriched plasma can replace dermis temporarily, besides being a robust scaffold for the growth of keratinocytes [13] .
The benefits of living keratinocytes in the epidermal compartment and/or living fibroblasts in the dermal compartment above an acellular dressing have now been widely accepted: living skin substitutes secrete a cocktail of cytokines, chemokines and growth factors that promote wound healing (by stimulating angiogenesis, granulation tissue formation and epithelialisation) as well as providing an immediate cover for the wound [14] [15] [16] .
We performed numerous tests varying the quantity of the scaffold components (CaCl 2, tranexamic acid, plasma and physiological solution), the quantity of keratinocytes and [17] [18] .
This kind of therapy is ideal for patients with chronic defects requiring continuous grafts. 
